Dexamethasone 21-phosphate disodium salt
SIGMA/D1159 - ≥98%
CAS Number: 2392-39-4
Empirical Formula (Hill Notation): C22H28FNa2O8P
Molecular Weight: 516.40
EC Number: 219-243-0
MDL Number: MFCD00079105
Linear Formula: C22H28FNa2O8P
Product Type: Chemical
| assay | ≥98% |
| color | white to off-white |
| form | powder |
| impurities | ≤1% ethanol |
| InChI | 1S/C22H30FO8P.2Na/c1-12-8 |
| InChI key | PLCQGRYPOISRTQ-FCJDYXGNSA |
| Quality Level | 100 ![]() |
| SMILES string | [Na+].[Na+].[H][C@@]12CCC |
| storage temp. | 2-8°C |
| Application: | Dexamethasone 21-phosphate disodium salt has been used: • as a positive control to study its effects on ocular shedding of herpes simplex virus type 1 (HSV-1) in the induced reactivation (IR) and spontaneous shedding (SS) rabbit models • as a receptor analog to study its effects on glucocorticoid receptor activation in suprachiasmatic nuclei (SCN)-lesioned mice • to study its protective effects against cisplatin-induced ototoxicity in the inner ear of guinea pigs |
| Biochem/physiol Actions: | Dexamethasone 21-phosphate (Dex 21-P) is a pro-drug that can undergo dephosphorylation to form dexamethasone with the help of intra-erythrocyte enzymes. It exhibits therapeutic effects against cystic fibrosis and postoperative cataract. Dex 21-P disodium salt is a synthetic adrenal corticosteroid and possesses anti-inflammatory activity. |
| Packaging: | 1, 5 g in glass bottle |
| Packaging: | 100, 500 mg in glass bottle |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H302 - H361d |
| Precautionary statements | P201 - P301 + P312 + P330 - P308 + P313 |
| Hazard Codes | Xn |
| Risk Statements | 63-22-40 |
| Safety Statements | 36/37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% |
| Storage Temp. | 2-8°C |
| UNSPSC | 51422340 |



